-
What I take away from watching the filmed version of ‘Hamilton’
Last week, my girlfriend and I caught the 2020 filmed version of Lin-Manuel Miranda’s award-winning […]
-
Viltepso fails main goal in confirmatory Phase 3 study
After nearly a year of treatment, Viltepso (viltolarsen) was well tolerated and tended to increase […]
-
NS Pharma Shares Update on VILTEPSO® (Viltolarsen) Phase 3 Study
NS Pharma, Inc. has shared preliminary analysis results from RACER53, the global Phase 3 clinical […]
-
Meeting of the Minds 2024
As we prepare to welcome families to the CureDuchenne FUTURES Annual Conference, scientific leaders, executives […]
-
Our son’s graduation from high school was beautifully exhausting
My oldest son, Max, 18, graduated from high school last Sunday. Graduation is a milestone […]
-
hC Bioscience Announces Program in Duchenne Muscular Dystrophy and Reports In Vivo Data From tRNA-based Protein Editing Platform
As a funder of hC Bioscience, we’re happy to have them announcing their tRNA-based approach […]
-
Study highlights psychological, social challenges of living with DMD
Duchenne muscular dystrophy (DMD) can make it harder to engage in social activities, and patients […]
-
Awareness Initiatives and Innovative Therapeutic Approaches Bring Hope to People Living with Becker Muscular Dystrophy
The following content is sponsored by Edgewise Therapeutics and does not reflect the views of […]
-
Dyne Therapeutics Shares New Clinical Data from DELIVER Trial of DYNE-251 in Duchenne Patients
Dyne Therapeutics has shared new clinical data from the ongoing DELIVER trial of DYNE-251 in […]
-
Study to Explore Barriers to Diverse Clinical Trial Participation in Duchenne Published
PPMD is pleased to share that the article, “Barriers to diverse clinical trial participation in […]
